Tech Company Financing Transactions

Umoja Biopharma Funding Round

On 6/16/2021, Umoja Biopharma received $210 million in Series B funding from Cormorant Asset Management, SoftBank Vision Fund and Alexandria Venture Investments.

Transaction Overview

Company Name
Announced On
6/16/2021
Transaction Type
Venture Equity
Amount
$210,000,000
Round
Series B
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1920 Terry Ave.
Seattle, WA 98101
USA
Phone
Undisclosed
Email Address
Overview
Umoja is driven by a bold and unified vision to transform cancer treatment and improve quality of life. We are a diverse group of drug development experts, scientists and researchers that are skilled, passionate, persistent, and relentlessly committed to finding a way to break through the current challenges encountered in immuno-oncology.
Profile
Umoja Biopharma LinkedIn Company Profile
Social Media
Umoja Biopharma Company Twitter Account
Company News
Umoja Biopharma News
Facebook
Umoja Biopharma on Facebook
YouTube
Umoja Biopharma on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Andrew Scharenberg
  Andrew Scharenberg LinkedIn Profile  Andrew Scharenberg Twitter Account  Andrew Scharenberg News  Andrew Scharenberg on Facebook
Chief Financial Officer
Irena Melnikova
  Irena Melnikova LinkedIn Profile  Irena Melnikova Twitter Account  Irena Melnikova News  Irena Melnikova on Facebook
Chief Medical Officer
Nushmia Khokhar
  Nushmia Khokhar LinkedIn Profile  Nushmia Khokhar Twitter Account  Nushmia Khokhar News  Nushmia Khokhar on Facebook
Chief Technical Officer
Ryan Crisman
  Ryan Crisman LinkedIn Profile  Ryan Crisman Twitter Account  Ryan Crisman News  Ryan Crisman on Facebook
Controller
Kelli Carabello
  Kelli Carabello LinkedIn Profile  Kelli Carabello Twitter Account  Kelli Carabello News  Kelli Carabello on Facebook
Vice President
Jacob Garcia
  Jacob Garcia LinkedIn Profile  Jacob Garcia Twitter Account  Jacob Garcia News  Jacob Garcia on Facebook
Vice President
Rich Getto
  Rich Getto LinkedIn Profile  Rich Getto Twitter Account  Rich Getto News  Rich Getto on Facebook
Vice President
Byoung Ryu
  Byoung Ryu LinkedIn Profile  Byoung Ryu Twitter Account  Byoung Ryu News  Byoung Ryu on Facebook
VP - Bus. Development
David Fontana
  David Fontana LinkedIn Profile  David Fontana Twitter Account  David Fontana News  David Fontana on Facebook
VP - Bus. Development
Timothy Gardner
  Timothy Gardner LinkedIn Profile  Timothy Gardner Twitter Account  Timothy Gardner News  Timothy Gardner on Facebook
VP - Operations
Gretchen Torrey
  Gretchen Torrey LinkedIn Profile  Gretchen Torrey Twitter Account  Gretchen Torrey News  Gretchen Torrey on Facebook
VP - Product Management
Bruce Kerwin
  Bruce Kerwin LinkedIn Profile  Bruce Kerwin Twitter Account  Bruce Kerwin News  Bruce Kerwin on Facebook
VP - Regulatory Affairs
Helen Kim
  Helen Kim LinkedIn Profile  Helen Kim Twitter Account  Helen Kim News  Helen Kim on Facebook
VP - Regulatory Affairs
Sagar Patel
  Sagar Patel LinkedIn Profile  Sagar Patel Twitter Account  Sagar Patel News  Sagar Patel on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/16/2021: Addepar venture capital transaction
Next: 6/16/2021: IRL venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here come from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary